| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1047507252 |
| P356 | DOI | 10.1038/SREP26848 |
| P3181 | OpenCitations bibliographic resource ID | 1028931 |
| P932 | PMC publication ID | 4893622 |
| P698 | PubMed publication ID | 27264087 |
| P50 | author | David J Scurr | Q39064931 |
| P2093 | author name string | George Hamilton | |
| Achala de Mel | |||
| William Everett | |||
| Arnold Darbyshire | |||
| Anna Rammou | |||
| P2860 | cites work | A novel nanocomposite polymer for development of synthetic heart valve leaflets. | Q53391252 |
| Nitric oxide-eluting nanocomposite for cardiovascular implants. | Q53662133 | ||
| Effects of nitric oxide-related agents on rat testicular function | Q71621226 | ||
| Preparation and characterization of hydrophobic polymeric films that are thromboresistant via nitric oxide release | Q73321021 | ||
| Supplemental dietary arginine enhances wound healing in normal but not inducible nitric oxide synthase knockout mice | Q74100048 | ||
| In vitro hemocompatibility testing of biomaterials according to the ISO 10993-4 | Q74684965 | ||
| Fibrinogen adsorption, platelet adhesion and activation on mixed hydroxyl-/methyl-terminated self-assembled monolayers | Q79912401 | ||
| Standardized methods to quantify thrombogenicity of blood-contacting materials via thromboelastography | Q82605156 | ||
| Small calibre polyhedral oligomeric silsesquioxane nanocomposite cardiovascular grafts: influence of porosity on the structure, haemocompatibility and mechanical properties | Q84565510 | ||
| L-arginine transport and nitric oxide synthesis in human endothelial progenitor cells | Q85410762 | ||
| Ghrelin induces growth hormone secretion via a nitric oxide/cGMP signalling pathway. | Q42523845 | ||
| Promotion of proliferation of murine BALB/C3T3 fibroblasts mediated by nitric oxide at lower concentrations. | Q42803164 | ||
| In situ endothelialization potential of a biofunctionalised nanocomposite biomaterial-based small diameter bypass graft | Q43204521 | ||
| Development of a hybrid cardiovascular graft using a tissue engineering approach. | Q44012009 | ||
| Synthesis and characterization of polymethacrylate-based nitric oxide donors | Q44173278 | ||
| Fumed silica nanoparticle mediated biomimicry for optimal cell-material interactions for artificial organ development | Q45885399 | ||
| Effect of pore size and interpore distance on endothelial cell growth on polymers | Q46804488 | ||
| Chondrogenesis of adipose stem cells in a porous polymer scaffold: influence of the pore size | Q47315524 | ||
| Platelet adhesion onto wettability gradient surfaces in the absence and presence of plasma proteins | Q47933083 | ||
| Methylesters of L-arginine and N-nitro-L-arginine induce nitric oxide synthase in Staphylococcus aureus | Q48018804 | ||
| NO synthase isozymes have distinct substrate binding sites. | Q48543074 | ||
| Role of the testis in the response of the pituitary-testicular axis to nitric oxide-related agents. | Q48618694 | ||
| Optimal endothelialisation of a new compliant poly(carbonate-urea)urethane vascular graft with effect of physiological shear stress. | Q50508761 | ||
| Heparin bioconjugate with a thermoresponsive cationic branched polymer: a novel aqueous antithrombogenic coating material. | Q50978656 | ||
| The antithrombogenic potential of a polyhedral oligomeric silsesquioxane (POSS) nanocomposite. | Q51292393 | ||
| Obstacles in haemocompatibility testing | Q27004486 | ||
| Endothelial nitric oxide synthase in vascular disease: from marvel to menace | Q28305279 | ||
| Alternative nitric oxide-producing substrates for NO synthases | Q33207400 | ||
| Biomaterials for vascular tissue engineering | Q33655808 | ||
| Enzymatic function of nitric oxide synthases | Q33847576 | ||
| The clinical pharmacology of L-arginine | Q33939368 | ||
| Polymer-Based Nitric Oxide Therapies: Recent Insights for Biomedical Applications | Q33951477 | ||
| Microencapsulation: A promising technique for controlled drug delivery | Q34185709 | ||
| Nitric oxide synthetic pathway in red blood cells is impaired in coronary artery disease | Q34934327 | ||
| O-phthalaldehyde: fluorogenic detection of primary amines in the picomole range. Comparison with fluorescamine and ninhydrin | Q35070123 | ||
| The catastrophe revisited: blood compatibility in the 21st Century | Q36103108 | ||
| In vitro endothelialization of electrospun terpolymer scaffolds: evaluation of scaffold type and cell source. | Q36490773 | ||
| Addressing thrombogenicity in vascular graft construction | Q36641036 | ||
| A biologically active surface enzyme assembly that attenuates thrombus formation. | Q36712188 | ||
| Cell colonization in degradable 3D porous matrices | Q37081819 | ||
| Surface chemistry influences implant biocompatibility | Q37130897 | ||
| Polymer scaffolds for small-diameter vascular tissue engineering | Q37547926 | ||
| Hemocompatibility Comparison of Biomedical Grade Polymers Using Rabbit Thrombogenicity Model for Preparing Nonthrombogenic Nitric Oxide Releasing Surfaces | Q37634574 | ||
| L-arginine stimulates fibroblast proliferation through the GPRC6A-ERK1/2 and PI3K/Akt pathway | Q37652404 | ||
| Thromboelastographic study of biomaterials. | Q37768388 | ||
| Nitric oxide: a guardian for vascular grafts? | Q37887771 | ||
| A standardized technique for performing thromboelastography in rodents. | Q38829684 | ||
| A novel method for the extraction and culture of progenitor stem cells from human peripheral blood for use in regenerative medicine. | Q39697934 | ||
| A Biocompatible Arginine-based Polycation. | Q42170088 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 26848 | |
| P577 | publication date | 2016-06-06 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | A Material Conferring Hemocompatibility | |
| P478 | volume | 6 |
| Q52737230 | Biomimetic heterogenous elastic tissue development. |
| Q50258998 | Dual-acting biofunctionalised scaffolds for applications in regenerative medicine. |
| Q47753623 | Introduction of Nature's Complexity in Engineered Blood-compatible Biomaterials. |
| Q39147255 | Tubular organ epithelialisation |
| Q88944330 | Tunable Elastomers with an Antithrombotic Component for Cardiovascular Applications |
Search more.